ADVANCE NSE filing

Advance Agrolife Q4 FY26 PAT Soars 422% to ₹74.61 Million on 40% Revenue Growth

The RealCase readHigh impact Positive

Advance Agrolife Limited reported a 422% surge in Q4 FY26 PAT to ₹74.61 million on 40% revenue growth to ₹1259.07 million. FY26 revenue increased 28% to ₹6417.5 million, with PAT up 38% to ₹352.84 million. The company is expanding manufacturing capabilities with new units and strengthening backward integration.

Why it matters

The substantial increase in profitability, revenue growth, and strategic expansion plans indicate a strong positive impact on the company's financial health and future prospects.

The market read

The company has reported significant year-on-year growth in revenue and profits, along with positive operational developments and credit rating upgrades.

Advance Agrolife Limited (AAL), formerly Advance Agrolife Private Limited, has announced its audited financial results for the fourth quarter and the full year ended March 31, 2026. The company reported a significant increase in profitability, with Profit After Tax (PAT) for Q4 FY26 reaching ₹74.61 million, a substantial rise of 422% compared to the same period last year. Total revenue for the quarter also saw robust growth, increasing by 40% year-on-year to ₹1259.07 million.

For the full fiscal year 2026, AAL's revenue grew by 28% to ₹6417.5 million, while PAT increased by 38% to ₹352.84 million. EBITDA for Q4 FY26 surged by 128% year-on-year to ₹133.8 million, with a corresponding EBITDA margin improvement of 425 basis points to 10.8%. For the full year, EBITDA rose by 34% to ₹636.9 million, with margins up by 50 basis points to 9.99%.

In terms of operational developments, AAL has strengthened its backward integration by commencing production of Pretilachlor Technical and its intermediate PEDA at its Jaipur facility. CARE Ratings upgraded AAL's long-term bank facilities from BBB to BBB+. The company is also in the process of setting up a 3.75 MW solar power plant and aims to commence operations at its new Unit-4 technical manufacturing facility in Gidani, Rajasthan, by Q2 FY27 with an initial capital expenditure of ₹250 million. Furthermore, AAL has entered into an MOU to acquire land in Dahej, Gujarat, for a new plant, Unit-5, dedicated to manufacturing technical-grade pesticides.

Mr. Omprakash Choudhary, CMD of Advance Agrolife Limited, commented that the company delivered a strong performance in FY26, driven by improved internal efficiencies, backward integration, customer base expansion, and its role as a reliable partner. He congratulated the team for the performance in the first year post the company's listing in October 2025 and expressed anticipation for FY2027.

Filing to action

What to do with a filing like this

Advance Agrolife Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Advance Agrolife Limited. Read the original for the full detail.

View original filing